Correction to: REALMS study: real-world effectiveness and safety of fingolimod in patients with relapsing-remitting multiple sclerosis in Portugal
Batista, S., Nunes, C. C., Cerqueira, J. J., Silva, Ana Martins, de Sá, J. Correia, Ferreira, J., Mendonça, M. T., Pinheiro, J., Salgado, V., Correia, A. S., Sequeira, J., Costa, A., Sousa, L.Journal:
Neurological Sciences
DOI:
10.1007/s10072-020-04879-4
Date:
November, 2020
File:
PDF, 104 KB
2020